Literature DB >> 18032455

Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency.

S A Thompson1, J Calvin, S Hogg, S Ferdinandusse, R J A Wanders, R A Barker.   

Abstract

Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare disorder of fatty acid metabolism which has recently been described in three adult cases. We have identified a further patient with clinical features of a relapsing encephalopathy, seizures and cognitive decline over a 40 year period. Biochemical studies revealed grossly elevated plasma pristanic acid levels, and a deficiency of AMACR in skin fibroblasts. Sequence analysis of AMACR cDNA identified a homozygous point mutation (c154T>C). This case adds to the phenotypic variation seen in this peroxisomal disorder and highlights the importance of screening for plasma pristanic acid levels in patients with unexplained relapsing encephalopathies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032455     DOI: 10.1136/jnnp.2007.129478

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Non-synonymous variants in the AMACR gene are associated with schizophrenia.

Authors:  Irina N Bespalova; Martina Durner; Benjamin P Ritter; Gary W Angelo; Enrique Rossy-Fullana; Jose Carrion-Baralt; James Schmeidler; Jeremy M Silverman
Journal:  Schizophr Res       Date:  2010-09-26       Impact factor: 4.939

2.  AMACR mutations cause late-onset autosomal recessive cerebellar ataxia.

Authors:  David Dick; Rita Horvath; Patrick F Chinnery
Journal:  Neurology       Date:  2011-05-17       Impact factor: 9.910

3.  Neurochemical evidence that pristanic acid impairs energy production and inhibits synaptic Na(+), K(+)-ATPase activity in brain of young rats.

Authors:  Estela Natacha Brandt Busanello; Carolina Maso Viegas; Anelise Miotti Tonin; Mateus Grings; Alana Pimentel Moura; Anderson Büker de Oliveira; Paula Eichler; Moacir Wajner
Journal:  Neurochem Res       Date:  2011-03-29       Impact factor: 3.996

4.  An overview of inborn errors of complex lipid biosynthesis and remodelling.

Authors:  Foudil Lamari; Fanny Mochel; Jean-Marie Saudubray
Journal:  J Inherit Metab Dis       Date:  2014-09-20       Impact factor: 4.982

Review 5.  Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.

Authors:  Paul P Van Veldhoven
Journal:  J Lipid Res       Date:  2010-06-17       Impact factor: 5.922

6.  An adult onset case of alpha-methyl-acyl-CoA racemase deficiency.

Authors:  Emily Helen Smith; Dimitar K Gavrilov; Devin Oglesbee; William D Freeman; Michael W Vavra; Dietrich Matern; Silvia Tortorelli
Journal:  J Inherit Metab Dis       Date:  2010-09-04       Impact factor: 4.982

7.  Exome sequences of multiplex, multigenerational families reveal schizophrenia risk loci with potential implications for neurocognitive performance.

Authors:  Mark Z Kos; Melanie A Carless; Juan Peralta; Joanne E Curran; Ellen E Quillen; Marcio Almeida; August Blackburn; Lucy Blondell; David R Roalf; Michael F Pogue-Geile; Ruben C Gur; Harald H H Göring; Vishwajit L Nimgaonkar; Raquel E Gur; Laura Almasy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-09-13       Impact factor: 3.568

Review 8.  Peroxisomes in brain development and function.

Authors:  Johannes Berger; Fabian Dorninger; Sonja Forss-Petter; Markus Kunze
Journal:  Biochim Biophys Acta       Date:  2015-12-11

9.  MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing.

Authors:  Kristoffer Haugarvoll; Stefan Johansson; Charalampos Tzoulis; Bjørn Ivar Haukanes; Cecilie Bredrup; Gesche Neckelmann; Helge Boman; Per Morten Knappskog; Laurence A Bindoff
Journal:  Orphanet J Rare Dis       Date:  2013-01-03       Impact factor: 4.123

10.  Asymptomatic retinal dysfunction in alpha-methylacyl-CoA racemase deficiency.

Authors:  Abrar K Alsalamah; Arif O Khan
Journal:  Mol Vis       Date:  2021-07-01       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.